Publisher
Springer Science and Business Media LLC
Reference6 articles.
1. Jastreboff AM, Kaplan LM, Frias JP, et al. Triple-hormone-receptor agonist retatrutide for obesity—a phase 2 trial. N Engl J Med. 2023;389:514–26.
2. Pirlet C, Ruzsa Z, Nemes B, Poirier P, Bertrand OF. Long-term outcomes and weight loss after bariatric embolization of the left gastric artery. J Invasive Cardiol. 2020;32:310–4.
3. Reddy VY, Neuzil P, Musikantow D, et al. Transcatheter bariatric embolotherapy for weight reduction in Obesity. J Am Coll Cardiol. 2020;76:2305–17.
4. Diana M, Pop R, Beaujeux R, et al. Embolization of arterial gastric supply in obesity (EMBARGO): an endovascular approach in the management of morbid obesity. Proof of the concept in the porcine model. Obes Surg. 2015;25:550–8.
5. di Giuseppe R, Hansel B, PuyraimondZemmour J, Vilgrain V, Ronot M, Garzelli L. Adding short to left gastric artery embolization for the treatment of obesity safety and effectiveness. Cardiovasc Intervent Radiol. 2024. https://doi.org/10.1007/s00270-024-03702-3.